Professor, Medicine, University of Louisville School of Medicine
Pediatric Cardiology
Dr. Emma J. Birks, MD
|
|
Give Review
Emma Birks practices Pediatric Cardiology. Emma Birks is a published MD. She has 95 publications published. The most current publication "Role of nitric oxide following cardiac transplantation." She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography.
- Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
- An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) ...
- Hematologic Markers Better Predict Left Ventricular Assist Device Thrombosis than Echocardiographic or Pump Parameters.
- Treatment strategies for myocardial recovery in heart failure.
- The Association of Pre-transplant HeartMate® II Left Ventricular Assist Device Placement and Heart Transplantation Mortality.
- Vascular endothelial growth factor in heart failure.
- HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial.
- Percutaneous Closure of a Patent Foramen Ovale to Prevent Paradoxical Thromboembolism in a Patient With a Continuous-Flow LVAD.
- Telethonin Deficiency Is Associated With Maladaptation to Biomechanical Stress in the Mammalian Heart.
- Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices.
- Destination therapy with left ventricular assist devices: patient selection and outcomes.
- Reverse Remodelling and Recovery from Heart Failure Are Associated with Complex Patterns of Gene Expression.
- Clinical, molecular, and genomic changes in response to a left ventricular assist device.
- Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
- A changing trend toward destination therapy: are we treating the same patients differently?
- Molecular changes occurring during reverse remodelling following left ventricular assist device support.
- Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds.
- Myocardial recovery in patients with chronic heart failure: is it real?
- Comparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate t...
- Sustained myocardial recovery 5 years after in situ disconnection of a Jarvik 2000 device.
- The comparative use of ventricular assist devices: differences between Europe and the United States.
- Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump.
- Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.
- Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
- Expression of follistatin-related genes is altered in heart failure.
- Bridge to decision using the Levitronix CentriMag short-term ventricular assist device.
- Quality of life after removal of left ventricular assist device for myocardial recovery.
- Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery.
- Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.
- Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device su...
- Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK).
- A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure ...
- Left ventricular assist device and drug therapy for the reversal of heart failure.
- In vitro endothelial cell activation and inflammatory responses in end-stage heart failure.
- Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local crea...
- Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation.
- Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
- Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
- Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location--relevance to membrane integrity, microstructure, and possible role in h...
- Transplantation using hearts from primary pulmonary hypertensive donors for recipients with a high pulmonary vascular resistance.
- Heart transplantation from live donors: "domino procedure".
- C34T AMP deaminase 1 gene mutation protects cardiac function in donors.
- The role of bridge to transplantation: should LVAD patients be transplanted?
- Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.
- Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.
- Images in cardiovascular medicine. Temporal and spatial changes in left ventricular pattern of flow during continuous assist device "HeartMate II".
- The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance.
- Heart transplant vs left ventricular assist device in heart transplant-eligible patients.
- Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.
- Overexpression of the transcription factor Hand1 causes predisposition towards arrhythmia in mice.
- Bridge to transplantation with a left ventricular assist device for systemic ventricular failure after Mustard procedure.
- Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.
- Acinetobacter mediastinitis in a heart transplant patient.
- Minimally invasive technique for explantation of right ventricular assist devices.
- Expression of human membrane skeleton protein genes for protein 4.1 and betaIISigma2-spectrin assayed by real-time RT-PCR.
- Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices.
- Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
- Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery ...
- Pulmonary autograft versus aortic homograft for aortic valve replacement: interim results from a prospective randomized trial.
- A prospective study of plasma nitrates following human heart transplantation-relevance to myocardial function.
- Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calciu...
- Incidence and clinical management of life-threatening left ventricular assist device failure.
- Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
- AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
- The role of nitric oxide and cytokines in heart failure.
- Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root.
- Role of nitric oxide following cardiac transplantation.
- The aortic outflow and root: a tale of dynamism and crosstalk.
- Early and long-term results of a valve-sparing operation for Marfan syndrome.
- Patient outcome and valve performance following a second aortic valve homograft replacement.
- A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized t...
- Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation.
- Aortic root characteristics of human pulmonary autografts.
- Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts.
- Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts.
- Serum cytokines in left ventricular assist device candidates.
- Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure.
- Cloning of dexamethasone-induced transcript: a novel glucocorticoid-induced gene that is upregulated in emphysema.
- Molecular and cellular mechanisms of donor heart dysfunction.
- A novel combination therapy to reverse end-stage heart failure.
- Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices.
- Clinical performance with the Levitronix Centrimag short-term ventricular assist device.
- Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery.
- Left ventricular assist devices.
- Pulmonary autograft versus homograft replacement of the aortic valve: a prospective randomized trial.
- Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
- Upregulation of the Bcl-2 family of proteins in end stage heart failure.
- Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes.
- Lung fibrosis as a potential complication of the hemostatic tissue sealant, biologic glue (Bioglue).
- Sensitization following LVAD implantation using leucodepleted blood is not due to HLA antibodies.
- Occult biliary injury after laparoscopic cholecystectomy.
- Risk factors for failure to thrive: a population-based survey.
- Effect of community based management in failure to thrive: randomised controlled trial.
Schools
Royal Free Hospital School Of MedicineUniversity Of London
Basildon Hospital Nethermayne
Harefield Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Doctors Specialties
- Cardiology
- Pediatric Cardiology
Accepted Insurances
Hospital
-
Jewish Hospital -
University of Louisville Hospital -
Kosair Children's Hospital
Drug Facts
| NPI NUMBER | 1962730499 | |
| NPPES Provider LastName | BIRKS | |
| NPPES Provider FirstName | EMMA | |
| NPPES Provider ZIPCode | 402023841 | |
| NPPES Provider State | KY | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1235.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 0.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962730499 |
| Last Name Of The Provider | BIRKS |
| First Name Of The Provider | EMMA |
| View All |
Similar Doctors
|
Dr. Joshua D. Sparks, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Morris M. Weiss Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John T. Kenny, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward S. Kim, MD |
|
Dr. Ryan A. Leahy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James W. Boone, MD |
|
Dr. Robert A. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rodney M. Miguel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frederick W. Arensman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ziad Alnabki, MD |
|
|
Dr. Matthew C. Keith, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ashley E. Neal, MD
This Doctor is OpenDoctor Recommended.
|